Starpharma Holdings Ltd (SPL)

0.685
+0.015(+2.24%)
  • Volume:
    318,589
  • Bid/Ask:
    0.680/0.685
  • Day's Range:
    0.650 - 0.720

SPL Overview

Prev. Close
0.67
Day's Range
0.65-0.72
Revenue
4.23M
Open
0.65
52 wk Range
0.62-1.545
EPS
-0.04
Volume
318,589
Market Cap
281.14M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
372,543
P/E Ratio
-
Beta
1.23
1-Year Change
-52.7%
Shares Outstanding
407,444,414
Next Earnings Date
30 Aug 2022
What is your sentiment on Starpharma Holdings?
or
Vote to see community's results!

Starpharma Holdings Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Starpharma Holdings Ltd Company Profile

Starpharma Holdings Ltd Company Profile

Employees
0
Market
Australia

Starpharma Holdings Limited is an Australia-based global biopharmaceutical company engaged in the development of pharmaceutical and medical products based on polymers called dendrimers. Its programs for respiratory viruses, Dendrimer Enhanced Product (DEP) drug delivery and VivaGel. The Company’s products include VIRALEZE, VivaGel condom and VivaGel BV. VIRALEZE product is applied to the nasal cavity where respiratory viruses that cause colds, flu, and more severe respiratory illness, attach and start to multiply. VIRALEZE also provides a moisturizing and protective barrier in the nose and contains SPL7013. VivaGel is an agent applied to a range of marketed women’s health and sexual wellness products. VivaGel BV is a novel therapy for bacterial vaginosis (BV), the vaginal infection. VivaGelBV is available for sale under the brand names Betafem BV Gel (UK), Betadine BV (Europe), Betadine BV Gel (Asia) and Fleurstat BVgel (Australia & New Zealand) and licensed in over 160 countries.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Sell
SummaryStrong BuyStrong BuyStrong BuySellStrong Sell